Benzinga | Aug 5, 2020 01:22PM EDT

BioLineRx Granted Australian Patent Number 2014343214 Titled 'Methods of treating acute myeloid leukemia with a FLT3 mutation'

http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2014343214#